Client Communications - Prime Therapeutics

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Who we are
Our solutions
Read, watch, listen
Pharmacy
Careers

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Home
Client Communication
Client Communications

Explore what's trending at Prime

https://www.primetherapeutics.com/w/read-update-on-executive-order-on-most-favored-nation-drug-pricing Example Link

Client news

READ: Update on Executive Order on Most-Favored-Nation drug pricing

May 13, 2025

https://www.primetherapeutics.com/w/view-the-latest-formulary-updates-notice Example Link

Client news

View the latest formulary updates notice

July 01, 2025

https://www.primetherapeutics.com/w/four-cybersecurity-tips-to-keep-your-data-secure Example Link

Client news

Four cybersecurity tips to keep your data secure

June 30, 2025

https://www.primetherapeutics.com/w/mid-market-central Example Link

Client news

Mid-Market Central

June 25, 2025

The Latest

Categories

CC Sub-Categories

https://www.primetherapeutics.com/w/four-cybersecurity-tips-to-keep-your-data-secure

Client news

Four cybersecurity tips to keep your data secure

June 30, 2025

https://www.primetherapeutics.com/w/read-prime-therapeutics-glp-1-year-3-data-press-release

Client news

READ: Prime Therapeutics GLP-1 Year-3 data press release

June 25, 2025

https://www.primetherapeutics.com/w/non-prime-glp-1-studies-and-prime-s-response

Client news

Non-Prime GLP-1 studies and Prime’s response

June 18, 2025

https://www.primetherapeutics.com/w/read-ira-faq-updates-june-2025

Client news

READ: IRA FAQ updates - June 2025

June 11, 2025

https://www.primetherapeutics.com/w/new-safeguards-for-secure-virtual-meetings-beginning-june-20

Client news

New safeguards for secure virtual meetings beginning June 20

June 10, 2025

https://www.primetherapeutics.com/w/june-drug-insights

Client news

READ: Featured Drug Insights: June 2025

June 09, 2025

https://www.primetherapeutics.com/w/read-clarification-evernorth-announces-new-glp-1-benefit

Client news

READ: Clarification: Evernorth announces new GLP-1 benefit

June 06, 2025

https://www.primetherapeutics.com/w/read-upcoming-cvs-closures-what-it-means-and-next-steps

Client news

READ: Upcoming CVS closures: What it means and next steps

June 04, 2025

https://www.primetherapeutics.com/w/read-overview-of-medicare-delinking-provisions-in-h-r-1

Client news

READ: Overview of Medicare delinking provisions in H.R. 1

June 02, 2025

Showing 1 to 9 of 107

Categories

CC Sub-Categories

https://www.primetherapeutics.com/w/view-the-latest-formulary-updates-notice

Client news

View the latest formulary updates notice

July 01, 2025

https://www.primetherapeutics.com/w/four-cybersecurity-tips-to-keep-your-data-secure

Client news

Four cybersecurity tips to keep your data secure

June 30, 2025

https://www.primetherapeutics.com/w/mid-market-central https://www.primetherapeutics.com/mid-market/

Client news

Mid-Market Central

June 25, 2025

https://www.primetherapeutics.com/w/read-prime-therapeutics-glp-1-year-3-data-press-release

Client news

READ: Prime Therapeutics GLP-1 Year-3 data press release

June 25, 2025

https://www.primetherapeutics.com/w/non-prime-glp-1-studies-and-prime-s-response

Client news

Non-Prime GLP-1 studies and Prime’s response

June 18, 2025

https://www.primetherapeutics.com/w/arkansas-rule-128-reporting-requirements-1-1

Client news

Arkansas Rule 128 reporting requirements

June 10, 2025

https://www.primetherapeutics.com/w/new-safeguards-for-secure-virtual-meetings-beginning-june-20

Client news

New safeguards for secure virtual meetings beginning June 20

June 10, 2025

https://www.primetherapeutics.com/w/june-drug-insights

Client news

READ: Featured Drug Insights: June 2025

June 09, 2025

https://www.primetherapeutics.com/w/read-upcoming-cvs-closures-what-it-means-and-next-steps

Client news

READ: Upcoming CVS closures: What it means and next steps

June 04, 2025

Showing 1 to 9 of 58

Categories

CC Sub-Categories

https://www.primetherapeutics.com/w/view-the-latest-formulary-updates-notice

Client news

View the latest formulary updates notice

July 01, 2025

https://www.primetherapeutics.com/w/four-cybersecurity-tips-to-keep-your-data-secure

Client news

Four cybersecurity tips to keep your data secure

June 30, 2025

https://www.primetherapeutics.com/w/read-prime-therapeutics-glp-1-year-3-data-press-release

Client news

READ: Prime Therapeutics GLP-1 Year-3 data press release

June 25, 2025

https://www.primetherapeutics.com/w/non-prime-glp-1-studies-and-prime-s-response

Client news

Non-Prime GLP-1 studies and Prime’s response

June 18, 2025

https://www.primetherapeutics.com/w/new-safeguards-for-secure-virtual-meetings-beginning-june-20

Client news

New safeguards for secure virtual meetings beginning June 20

June 10, 2025

https://www.primetherapeutics.com/w/june-drug-insights

Client news

READ: Featured Drug Insights: June 2025

June 09, 2025

https://www.primetherapeutics.com/w/read-upcoming-cvs-closures-what-it-means-and-next-steps

Client news

READ: Upcoming CVS closures: What it means and next steps

June 04, 2025

https://www.primetherapeutics.com/w/read-diabetic-and-asthma-products-added-to-amp-cap

Client news

READ: Diabetic and asthma products added to AMP cap

May 14, 2025

https://www.primetherapeutics.com/w/read-featured-drug-insights-may-2025

Client news

READ: Featured Drug Insights: May 2025

May 14, 2025

Showing 1 to 9 of 78

Categories

CC Sub-Categories

https://www.primetherapeutics.com/w/four-cybersecurity-tips-to-keep-your-data-secure

Client news

Four cybersecurity tips to keep your data secure

June 30, 2025

https://www.primetherapeutics.com/w/read-prime-therapeutics-glp-1-year-3-data-press-release

Client news

READ: Prime Therapeutics GLP-1 Year-3 data press release

June 25, 2025

https://www.primetherapeutics.com/w/non-prime-glp-1-studies-and-prime-s-response

Client news

Non-Prime GLP-1 studies and Prime’s response

June 18, 2025

https://www.primetherapeutics.com/w/new-safeguards-for-secure-virtual-meetings-beginning-june-20

Client news

New safeguards for secure virtual meetings beginning June 20

June 10, 2025

https://www.primetherapeutics.com/w/june-drug-insights

Client news

READ: Featured Drug Insights: June 2025

June 09, 2025

https://www.primetherapeutics.com/w/read-upcoming-cvs-closures-what-it-means-and-next-steps

Client news

READ: Upcoming CVS closures: What it means and next steps

June 04, 2025

https://www.primetherapeutics.com/w/read-featured-drug-insights-may-2025

Client news

READ: Featured Drug Insights: May 2025

May 14, 2025

https://www.primetherapeutics.com/w/read-update-on-executive-order-on-most-favored-nation-drug-pricing

Client news

READ: Update on Executive Order on Most-Favored-Nation drug pricing

May 13, 2025

https://www.primetherapeutics.com/w/read-featured-drug-insights-april-2025

Client news

READ: Featured Drug Insights: April 2025

April 29, 2025

Showing 1 to 9 of 56

Categories

CC Sub-Categories

https://www.primetherapeutics.com/w/four-cybersecurity-tips-to-keep-your-data-secure Example Link

Client news

Four cybersecurity tips to keep your data secure

June 30, 2025

https://www.primetherapeutics.com/w/read-prime-therapeutics-glp-1-year-3-data-press-release Example Link

Client news

READ: Prime Therapeutics GLP-1 Year-3 data press release

June 25, 2025

https://www.primetherapeutics.com/w/non-prime-glp-1-studies-and-prime-s-response Example Link

Client news

Non-Prime GLP-1 studies and Prime’s response

June 18, 2025

https://www.primetherapeutics.com/w/new-safeguards-for-secure-virtual-meetings-beginning-june-20 Example Link

Client news

New safeguards for secure virtual meetings beginning June 20

June 10, 2025

https://www.primetherapeutics.com/w/june-drug-insights Example Link

Client news

READ: Featured Drug Insights: June 2025

June 09, 2025

https://www.primetherapeutics.com/w/read-upcoming-cvs-closures-what-it-means-and-next-steps Example Link

Client news

READ: Upcoming CVS closures: What it means and next steps

June 04, 2025

https://www.primetherapeutics.com/w/read-featured-drug-insights-may-2025 Example Link

Client news

READ: Featured Drug Insights: May 2025

May 14, 2025

https://www.primetherapeutics.com/w/read-update-on-executive-order-on-most-favored-nation-drug-pricing Example Link

Client news

READ: Update on Executive Order on Most-Favored-Nation drug pricing

May 13, 2025

https://www.primetherapeutics.com/w/read-featured-drug-insights-april-2025 Example Link

Client news

READ: Featured Drug Insights: April 2025

April 29, 2025

Showing 1 to 9 of 63

Login Portals

Members and Consumers
Clients and Health Plans
Pharmacy + Provider Resources

Compliance / Legal

Privacy Policy
Notice of Privacy Practices
Terms of Use
Nondiscrimination + Languages
Subrogation

Company

About us
Careers
News
Media

Client Communications - Prime Therapeutics

About us

Corporate social responsibility

Solutions overview

Modern technology

Drug access

Clinical solutions

Condition management

Specialty drug management

Government solutions

Single-state programs

Read

Watch

Listen

Home Delivery

Specialty Pharmacy

Navigate to

Back

Back

Back

Back

Explore what's trending at Prime

READ: Update on Executive Order on Most-Favored-Nation drug pricing

View the latest formulary updates notice

Four cybersecurity tips to keep your data secure

Mid-Market Central

The Latest

Four cybersecurity tips to keep your data secure

READ: Prime Therapeutics GLP-1 Year-3 data press release

Non-Prime GLP-1 studies and Prime’s response

READ: IRA FAQ updates - June 2025

New safeguards for secure virtual meetings beginning June 20

READ: Featured Drug Insights: June 2025

READ: Clarification: Evernorth announces new GLP-1 benefit

READ: Upcoming CVS closures: What it means and next steps

READ: Overview of Medicare delinking provisions in H.R. 1

View the latest formulary updates notice

Four cybersecurity tips to keep your data secure

Mid-Market Central

READ: Prime Therapeutics GLP-1 Year-3 data press release

Non-Prime GLP-1 studies and Prime’s response

Arkansas Rule 128 reporting requirements

New safeguards for secure virtual meetings beginning June 20

READ: Featured Drug Insights: June 2025

READ: Upcoming CVS closures: What it means and next steps

View the latest formulary updates notice

Four cybersecurity tips to keep your data secure

READ: Prime Therapeutics GLP-1 Year-3 data press release

Non-Prime GLP-1 studies and Prime’s response

New safeguards for secure virtual meetings beginning June 20

READ: Featured Drug Insights: June 2025

READ: Upcoming CVS closures: What it means and next steps

READ: Diabetic and asthma products added to AMP cap

READ: Featured Drug Insights: May 2025

Four cybersecurity tips to keep your data secure

READ: Prime Therapeutics GLP-1 Year-3 data press release

Non-Prime GLP-1 studies and Prime’s response

New safeguards for secure virtual meetings beginning June 20

READ: Featured Drug Insights: June 2025

READ: Upcoming CVS closures: What it means and next steps

READ: Featured Drug Insights: May 2025

READ: Update on Executive Order on Most-Favored-Nation drug pricing

READ: Featured Drug Insights: April 2025

Four cybersecurity tips to keep your data secure

READ: Prime Therapeutics GLP-1 Year-3 data press release

Non-Prime GLP-1 studies and Prime’s response

New safeguards for secure virtual meetings beginning June 20

READ: Featured Drug Insights: June 2025

READ: Upcoming CVS closures: What it means and next steps

READ: Featured Drug Insights: May 2025

READ: Update on Executive Order on Most-Favored-Nation drug pricing

READ: Featured Drug Insights: April 2025

Login Portals

Compliance / Legal

Company